Skip to main content

Animations

MJFF Publications

6181 - 6190 of 9035 Results
Title
Year
  • Year
  • 2018
  • 2014
  • 2015
  • 2019
  • 2018
  • 2018
  • 2020
  • 2021
  • 2016
  • 2013
  • Summary Details
    OPEN
    Title: The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.644
    Citation Count: 686
  • Summary Details
    OPEN
    Title: Overcoming obstacles to repurposing for neurodegenerative disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.76
    Citation Count: 62
  • Genome‐wide variant by serum urate interaction in Parkinson's disease
    2015
    Summary Details
    RESTRICTED
    Title: Genome‐wide variant by serum urate interaction in Parkinson's disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24504
    Citation Count: 12
  • Higher urate in LRRK2 mutation carriers resistant to Parkinson disease
    2019
    Summary Details
    RESTRICTED
    Title: Higher urate in LRRK2 mutation carriers resistant to Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25436
    Citation Count: 56
  • Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease
    2018
    Summary Details
    RESTRICTED
    Title: Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25376
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Deep gray matter volume loss drives disability worsening in multiple sclerosis
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ana.25145
    Citation Count: 440
  • Summary Details
    OPEN
    Title: Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25687
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.5845
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2016.2245
    Citation Count: 224
  • Summary Details
    RESTRICTED
    Title: Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.3861
    Citation Count: 368
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.